Fulminant myocarditis following coronavirus disease 2019 vaccination: a case report

BACKGROUND: The BNT162b2 vaccine received emergency use authorization from the U.S. Food and Drug Administration for the prevention of severe coronavirus disease 2019 (COVID-19) infection. We report a case of biopsy and magnetic resonance imaging (MRI)-proven severe myocarditis that developed in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Agdamag, Arianne Clare C, Gonzalez, Daniel, Carlson, Katie, Konety, Suma, McDonald, William C, Martin, Cindy M, Maharaj, Valmiki, Alexy, Tamas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Grand Round
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790078/
https://www.ncbi.nlm.nih.gov/pubmed/35088026
http://dx.doi.org/10.1093/ehjcr/ytac007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790078/
https://www.ncbi.nlm.nih.gov/pubmed/35088026
http://dx.doi.org/10.1093/ehjcr/ytac007

Ejemplares similares